Table 1.
Characteristic | Participants (n = 63) |
---|---|
Age: mean ± SD years (range) | 42.5 ± 13.5 (21.0 – 78.0) |
Female: n (%) | 62 (98.4) |
Race: n (%) | |
White | 31 (49.2) |
Black | 15 (23.8) |
Asian | 9 (14.3) |
More than One Race | 5 (7.9) |
Not Reported | 3 (4.8) |
Ethnicity: n (%) | |
Hispanic/Latino | 10 (15.9) |
Insurance: n (%) | |
Medicaid | 14 (22.2) |
Medicare | 7 (11.1) |
Commercial | 42 (66.7) |
On Disability (by patient self-report): n (%) | 17 (27.0) |
Geographic Location: n (%) | |
Boston | 23 (36.5) |
New York | 40 (63.5) |
SLE Characteristics | |
SLE Disease Duration: mean ± SD years (range) | 10.9 ± 9.2 (0.5 – 44) |
SELENA-SLEDAI: mean ± SD (range) [Range 0 to 105, higher worse] | 3.3 ± 3.3 (0 – 14) |
SLICC/ACR Damage Index: mean ± SD (range) [Range 0 to 46, higher worse] | 1.0 ± 2.0 (0 – 13) |
Co-Morbid Conditions (by patient self-report) | |
Anxiety: n (%) | 14 (22.2) |
Depression: n (%) | 13 (20.6) |
Fibromyalgia: n (%) | 11 (17.5) |